Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients

• Egile Nagusiak: Maha A. Behairy (Egilea), Osama Mahmoud (Egilea), Ayman Rabie Ibrahim (Egilea), Aber H. Baki (Egilea)
• Formatua: Liburua
• Argitaratua: Society of Diabetic Nephropathy Prevention, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease-mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objectives: This multi-centric experience study aims to compa...